Pubblicazioni ufficiali Takeda Pharmaceutical Company Limited Börse Stuttgart

Azioni

Mercato chiuso - Börse Stuttgart Altri mercati azionari 14:27:19 21/06/2024			Variaz. 5gg	Var. 1 gen.
23,42 ^EUR	-0,13%		-3,42%	-9,18%

04:30	Takeda presenta i dati dell'ultimo studio di Fase 2b su Mezagitamab, dimostrando il potenziale di trasformazione del trattamento della trombocitopenia immunitaria primaria	CI
21/06	Takeda ottiene l'approvazione della Commissione Europea per il farmaco contro il cancro colorettale Fruzaqla	MT

Slide show results	09/05	CO
Annual results	09/05	CO
4th quarter report	09/05	CO
Slide show Q3	01/02	CO
3rd quarter results	01/02	CO
3rd quarter report	01/02	CO
Changes in management and corporate officers	18/01	CO
Slide show half-year results	26/10/23	CO
1st-half-year results	26/10/23	CO
Slide show Q1	27/07/23	CO
1st quarter results	27/07/23	CO
Minutes of the general assembly	28/06/23	CO
Mixed general shareholder meeting	06/06/23	CO
Slide show results	11/05/23	CO
Annual results	11/05/23	CO
Integrated report	31/03/23	CO
Annual Report	31/03/23	CO
Slide show Q3	02/02/23	CO
3rd quarter results	02/02/23	CO
3rd quarter report	02/02/23	CO
Slide show half-year results	27/10/22	CO
Half-year report	27/10/22	CO
1st quarter report	28/07/22	CO
Slide show Q1	28/07/22	CO
1st quarter results	28/07/22	CO